S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SURF Surface Oncology Inc

1.07

0.00 (0.00%)

May 09 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Surface Oncology (NASDAQ:SURF)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Surface Oncology Charts.

Surface Oncology (NASDAQ:SURF)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Surface Oncology Charts.

Surface Oncology Inc News

Form EFFECT - Notice of Effectiveness
Tuesday 12 September 2023 (8 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 31 August 2023 (8 months ago) • Edgar (US Regulatory)

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
Thursday 31 August 2023 (8 months ago) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 30 August 2023 (8 months ago) • Edgar (US Regulatory)

More Surface Oncology Inc News Articles

Osi Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions